Pulse pressure and arterial stiffness in rats: Comparison with humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Safar, Michel E ^a   Laurent, Pierre ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CICLETANINE; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; ISOSORBIDE DINITRATE; NEBIVOLOL; SINITRODIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

AGING; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTERY WALL; BLOOD VESSEL REACTIVITY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; HEMODYNAMICS; HUMAN; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE PRESSURE; SODIUM INTAKE; SPECIES DIFFERENCE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

EID: 0141676841     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00513.2003     Document Type: Editorial

References (63)

1. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, and Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 23: 74-82, 1994.
2. Asmar RG, London GM, O'Rourke ME, and Safar ME, and for the Reason project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 38: 922-926, 2001.
3. Bauersachs J, Bouloumie A, Mülsch A, Wiemer G, Flemeing I, and Busse R. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylate cyclase expression and in superoxide anion production. Cardiovasc Res 37: 772-779, 1998.
4. Benetos A, Bouaziz H, Albaladejo P, Guez D, and Safar M. Carotid artery mechanical properties of Dahl salt-sensitive rats. Hypertension 25: 272-277, 1995.
5. Benetos A, Lacolley P, and Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats (SHRs). Arterioscler Thromb Vasc Biol 17: 1152-1156, 1997.
6. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, and Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting-enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17: 3196-3201, 1997.
7. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension 34: 386-387, 1999.
8. Canty JM and Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 89: 375-384, 1994.
9. Caputo L, Benessiano J, Boulanger CM, and Levy BI. Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arterioscler Thromb Vasc Biol 15: 1646-1651, 1995.
10. Cernadas MR, De Miguel LS, Garcia-Duran M, Gonzalez-Fernandez F, Millas I, Monton M, Rodrigo J, Rico L, Fernandez P, Defrutost, Rodriguez-Feo Ja, Guerra J, Caramelo C, Casado S, and Lopez-Farre A. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 83: 279-286, 1998.
11. Chamiot-Clerc P, Renaud JF, Blacher J, Legrand M, Samuel JL, Levy Bi, Sassard J, and Safar ME. Collagen and III I and mechanical properties of conduit arteries in rats with genetic hypertension. J Vasc Res 36: 139-146, 1999.
12. Chamiot-Clerc PH, Renaud JF, and Safar ME. Pulse pressure, aortic reactivity and endothelium dysfunction in old hypertensive rats. Hypertension 37: 313-321, 2001.
13. Chou TZ, Yen MH, Li CY, and Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643-648, 1998.
14. Cocks TM and Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627-630, 1983.
15. Cunha R, Dabire H, Bezie I, Weiss AM, Chaouche-Teyara K, Laurent S, Safar M, and Lacolley P. Mechanical stress of the carotid artery at the early phase of spontaneous hypertension in rats. Hypertension 29: 992-998, 1997.
16. Duchier J, Iannascoli F, and Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic hypertension in the elderly. Am J Cardiol 60: 99-102, 1987.
17. Eccleston-Joyner CA and Gray SD. Arterial hypertrophy in the fetal and neonatal spontaneously hypertensive rats. Hypertension 12: 513-518, 1988.
18. Et-Taouil K, Schiavi P, Levy BI, and Plante GE. Sodium intake, large artery stiffness and proteoglycans in the SHR. Hypertension 38: 1172-1176, 2001.
19. Fitch RM, Vergona R, Sullivan ME, and Wang Y-X. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 51: 351-358, 2001.
20. Franklin SS, Gustin W IV, Wong ND, Larson MG, Weber MA, Kannel WB, and Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96: 308-315, 1997.
21. Frohlich ED, Pfeffer MA, and Pfeffer JM. Systemic hemodynamics and cardiac function in spontaneously hypertensive rats: similarities with essential hypertension. In: The Heart in Hypertension, edited by Strauer BE. Springer-Verlag: Berlin and New York, 1981, p. 53-71.
22. Gibbons GH, Pratt RE, and Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 90: 456-461, 1992.
23. Hutcheson IR and Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol Heart Circ Physiol 261: H257-H262, 1991.
24. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, Degroof RC, and Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product cross-link breaker. Circulation 104: 1464-1470, 2001.
25. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, and Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9: 17-22, 1991.
26. Kielty CM, Hopkinson I, and Grant ME. Collagen. The collagen family: structure, assembly and organization in the extracellular matrix. In: Connective Tissue and Its Inheritable Disorders: Molecular Genetic and Medical Aspects, edited by Royce PM and Steinmann B. New York: Wiley-Liss, 1993, p. 103-147.
27. Kiing CF and Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 25: 194-200, 1995.
28. Labat C, Lacolley P, Lajemi M, De Gasparo M, Safar ME, and Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 38: 439-443, 2001.
29. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, and Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt treated rats-effects of Eplerenone. Circulation 106: 2848-2853, 2002.
30. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, and Benetos A. Angiotensin type 1 receptor-153 A/G and 1166 A/C II. gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 19: 407-413, 2001.
31. Levy BI, Michel JB, Salzmann JL, Poitevin P, Devissaguet M, Scalbert E, and Safar ME. Angiotensine-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol Card 71: 8E-16E, 1993.
32. Levy BI, Poitevin P, Duriez M, Guez DC, Schiavi PD, and Safar ME. Sodium, survival and the mechanical properties of the carotid artery in stroke-prone hypertensive rats. J Hypertens 15: 251-258, 1997.
33. Lichtenstein O, Safar ME, Mathieu E, Poitevin P, and Levy BI. Static and dynamic mechanical properties of the carotid artery from normotensive and hypertensive rats. Hypertension 32: 346-350, 1998.
34. Limas C, Westrum B, Limas CJ, and Cohn JN. Effect of salt on the vascular lesions of spontaneously hypertensive rats. Hypertension 2: 477-489, 1980.
35. Marin J. Age-related changes in vascular responses: a review. Mech Ageing Dev 79: 71-114, 1995.
36. Marque V, Kieffer P, Atkinson J, and Lartaud-Idjouadienne I. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertension 34: 415-422, 1999.
37. Mattson DL. Comparison of arterial blood pressure in different strains of mice. Am J Hypertens 14: 405-408, 2001.
38. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E, Corman B, and Levi BI. Effect of chronic ANG I-converting enzyme inhibition of aging processes. II. Larges arteries. Am J Physiol Regul Integr Comp Physiol 267: R124-R135, 1994.
39. Milnor WR. Hemodynamics (2nd ed.). Baltimore, MD: Wilkins, 1989, p. 211-241.
40. Mizutani K, Ikeda K, Kawai Y, and Yamori Y. Biomechanical properties and chemical composition of the aorta in genetic hypertensive rats. J Hypertens 17: 481-487, 1999.
41. Mourad JJ, Ducailar G, Rudnichi A, Lajemi M, Mimram A, and Safar ME. Age-related increase of pulse pressure and gene polymorphisms in essential hypertension: a preliminary study. J Renin Angiotensin Aldosterone Syst 3: 109-115, 2002.
42. Nichols WW and O'Rourke M. McDonald's blood flow in arteries. Theoretical, Experimental and Clinical Principles (4th ed.). London, Sydney, Auckland: Arnold, 1998, p. 54-113, 201-222, 284-292, and 347-401.
43. O'Rourke M. Mechanical principles in arterial disease. Hypertension 26: 2-9, 1995.
44. Parry DAD. The molecular, and fibrillar structure of collagen and its relationship to the mechanical properties of connectivite tissue. Biophys Chem 29: 195-209, 1988.
45. Partovian C, Benetos A, Pommies JP, and Safar ME. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol Heart Circ Physiol 274: H1423-H1428, 1998.
46. Peng X, Haldar S, Deshpande S, Irani K, and Kass DA. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41: 378-381, 2003.
47. Pfeffer MA and Frolich D. Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res 32, Suppl I: I28-I38, 1973.
48. Radaelli A, Mircoli L, Mancia G, and Ferrari AU. Nitric oxide-dependent vasodilation in young spontaneously hypertensive rats. Hypertension 32: 735-739, 1998.
49. Ruschitzka F, Corti R, Noll G, and Lüscher TF. A rationale for treatment of endothelial dysfunction in hypertension. J Hypertens 17, Suppl 1: S25-S35, 1999.
50. Safar ME. Systolic blood pressure, pulse pressure, and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 10: 257-261, 2001.
51. Safar ME, Blacher J, Mourad JJ, and London GM. Stiffness of carotid artery wall material and blood pressure in humans. Stroke 31: 782-790, 2000.
52. Safar ME and London GM. The arterial system in human hypertension. In: Textbook of Hypertension, edited by Swales JD. London: Blackwell, 1994, p. 85-102.
53. Schwartz SM, Heimark RL, and Majesty MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev 70: 1177-1198, 1990.
54. Smulyan H, Asmar RG, Rudnichi A, London GM, and Safar ME. Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol 37: 1374-1380, 2001.
55. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, and Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: metaanalysis of outcome trials. Lancet 355: 865-872, 2000.
56. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger H, Herrmann SM, Fagard R, Tizzoni L, and Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a caucasian population. J Hypertens 19: 1349-1358, 2001.
57. Susic D, Varagic J, and Frohlich ED. Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition. Hypertension 38: 1422-1426, 2001.
58. The ALLHAT Officers, and Coordinators for the ALLHAT Collaborative Research Group. Major outcome in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288: 2991-2997, 2002.
59. Tobian L. Salt and hypertension: lessons from animal models that relate to human hypertension. Hypertension 17, Suppl I: S152-S158, 1991.
60. Tsoucaris D, Benetos A, Legrand M, London G, and Safar M. Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 13: 243-249, 1995
61. Tsoucaris-Kupfer D, Benetos A, Legrand M, and Safar M. Pulse pressure gradient along the aortic tree in normotensive Wistar-Kioto and spontaneously hypertensive rats: effect of nicardipine. J Hypertens 11: 135-139, 1993.
62. Van Bortel LM, Struijker-Boudier HA, and Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 38: 914-921, 2001.
63. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AO, and Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 105: 213-217, 2002.